-
FDA Renews and Expands its Use of Certara Software to Facilitate New Drug and Biologics Regulatory Review
Oct 9, 2018, 08:24 AM by Michael CroftPRINCETON, NJ, US - Oct 9, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applicationsFull story -
BioIVT Acquires UK-based Clinical Trials Laboratory Services
Oct 8, 2018, 10:55 AM by Michael CroftWESTBURY, NY, US - Oct 8, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UKFull story -
Repositive launches limited-time free Personal Shopper Service, to connect researchers with difficult-to-source translational cancer models
Oct 8, 2018, 08:57 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Oct 8, 2018 - Repositive launches limited-time free Personal Shopper Service, to connect researchers with difficult-to-source translational cancer modelsRepositive, the Cambridge (UK) tech start-up that connects oncology researchers with the world of cancer models and the services they require to develop new treatments and cures, has announced a limited-time, free of charge, introductory service to its Cancer Models productFull story -
Solentim Wins Two Queen’s Awards for Enterprise
Oct 8, 2018, 07:40 AM by Michael CroftWIMBORNE, UK - Oct 8, 2018 - Solentim, a leading provider of instrumentation used by biopharma companies in the fields of mammalian cell line development and cell culture, has received two Queen's Awards for Enterprise, one for International Trade and one for InnovationFull story -
Certara to Participate in 40 Pharmacometrics Modeling and Simulation Sessions at ACoP9
Oct 5, 2018, 20:46 PM by Michael CroftPRINCETON, NJ, US - Oct 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it is participating in 40 sessions at the ninth American Conference on Pharmacometrics (ACoP9)Full story -
GA4GH Holds Annual Event, Reports On Driver Projects
Oct 5, 2018, 14:50 PM by Michael CroftFull storyBio-IT World | The Global Alliance for Genomics and Health held its annual event this week, presenting the first set of deliverables developed under GA4GH Connect, the group’s 5-year strategic plan to enable real-world genomic data sharing by 2022, and opening the call for new GA4GH Driver projects.
-
Researchably’s New AI Solution Uses NLP To Sift Through Research
Oct 4, 2018, 10:40 AM by Michael CroftFull storyBio-IT World | Researchably, a startup in the UC Berkeley SkyDeck accelerator program, announced their natural language processing AI solution, which has the capability to read and review scientific articles, and determine to which departments they are most relevant faster, making far fewer errors than expert readers.
-
CluePoints Strengthens Senior Team with Two Key Appointments
Oct 4, 2018, 08:50 AM by Michael CroftWAYNE, PA - Oct 4, 2018 - CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced the appointment of two industry thought-leaders to its senior team, as it continues its impressive global growth throughout North America, Europe and Asia PacificFull story -
Riffyn launches Open Access for scientists at non-profits
Oct 3, 2018, 11:32 AM by Michael CroftOAKLAND, CA - Oct 3, 2018 - Oakland, CA, USA, 3rd October 2018 / Riffyn, a global provider of cloud-based experiment design and data analytics software, has launched Riffyn Open Access which provides free use of its patented Scientific Development Environment (SDE) to any member of a non-profit organizationFull story -
Vyasa Partners With Markley To Drive Deep Learning Innovation
Oct 3, 2018, 10:35 AM by Michael CroftFull storyBio-IT World News Brief | Vyasa announces that it has selected Markley to house its GPU-based compute infrastructure.
-
How Artificial Intelligence Is Changing Pharma And What’s Next
Oct 3, 2018, 08:00 AM by Michael CroftFull storyBio-IT World | Artificial intelligence and machine learning may still be decades away from their biggest impacts, but the technologies are already changing pharma and biotech.
-
Innovate UK Awards Medherant a Medicines Manufacturing Grant
Oct 3, 2018, 05:30 AM by Michael CroftCOVENTRY, UK - Oct 3, 2018 - Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UKFull story -
The DNA Data Storage Machine That’s The Size Of A School Bus
Oct 2, 2018, 10:50 AM by Michael CroftMIT Technology Review | A startup's concept drawing of a hulking device to archive data in DNA molecules shows the idea has a way to go.Full story -
SynbiCITE launches new five-year strategy
Oct 2, 2018, 09:39 AM by Michael CroftLONDON, UK - Oct 2, 2018 - SynbiCITE, the UKs national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sourcesFull story -
CRF Health, a CRF Bracket Company, Brings Industry Together to Lead Debate with eCOA Forum
Oct 2, 2018, 08:58 AM by Michael CroftPLYMOUTH MEETING, PA - Oct 2, 2018 - CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today unveiled details of its 2018 eCOA ForumFull story -
Knockout (KO) Validation
Oct 2, 2018, 08:53 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Oct 2, 2018 - Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased statesFull story -
Breakthrough Leukemia Treatment Backfires In A Rare Case
Oct 1, 2018, 15:32 PM by Michael CroftThe New York Times | A highly unusual death has exposed a weak spot in a groundbreaking cancer treatment: One rogue cell, genetically altered by the therapy, can spiral out of control in a patient and cause a fatal relapse.Full story -
Bio-IT World Launches Innovative Practices Awards, Opens Call For Entries
Oct 1, 2018, 07:40 AM by Michael CroftFull storyBio-IT World | In 2019 Bio-IT World is launching the Innovative Practices Awards, an elite awards program designed to recognize partnerships and projects pushing our industry forward.
-
Protein Dynamic Solutions recipient of NSF SBIR Phase IIB Supplemental award
Sep 30, 2018, 18:45 PM by Michael CroftWAKEFIELD, MA - Oct 1, 2018 - Protein Dynamic Solutions (PDS) was awardeda Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) to focus on innovative breakthrough applications and commercialization of ProteinMentorTMplatform technology for pre-clinical candidate selection and to help ensure safety and efficacy of therapeutic proteinsFull story -
UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR
Sep 28, 2018, 12:50 PM by Michael CroftBOSTON, MA - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programsFull story